GaliximabAgricultural BiotechnologyUpdated on Mar 3, 2020 View more like this | Visit SHIRLEY, NY | Contact Bella Smith |

Recombinant monoclonal antibody to CD8. Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009, The drug is a chimeric antibody from Macaca irus and Homo sapiens.